Monaco Raises Over €18,000 for Alzheimer’s Research and Patient Care
More than 18,000 euros have been raised for Alzheimer’s disease research and patient support in Monaco following a series of community fundraising events, according to campaign organizers.
- Over 18,000 euros were raised through the “Forget me not” event and the week-long “#MonacoBouge pour Ceux qui Oublient” initiative.
- All collected funds are designated for the Centre Rainier-III to establish a dedicated health pathway for Alzheimer’s patients.
- Public outreach efforts during the campaign included educational sessions in schools to shift perceptions regarding patients, caregivers, and medical staff.
Community Mobilization and Fundraising Outcomes
The fundraising campaign combined a solidarity walk with multi-day sporting activities to engage the local population. Kate Williams, who oversees the organization of #MonacoBouge, noted the broad community response. Local entities participated in the mobilization, including the Princely Government, the Town Hall of Monaco, the Yacht-club de Monaco, the Monégasque Academy of the Sea, Hercule fitness club, and ASM triathlon.
“Between the event ‘Forget me not’ and #MonacoBouge pour Ceux qui Oublient, one with a solidarity walk, the other staggered over a week with sporting activities to be carried out together, we mobilized a lot of people,” Williams stated.
Allocating Resources to Patient Pathways
The financial contributions secured during the mobilization week will fund a specialized health pathway within the Centre Rainier-III. Organizers emphasized that beyond securing financial support for research, the initiative prioritizes public health awareness. Educational interventions in local schools sought to alter societal perceptions of the neurodegenerative condition, focusing equally on the lived experiences of patients, family caregivers, and professional medical staff.
Comparative Regional Scope and Clinical Realities
The fundraising milestone in Monaco highlights ongoing regional mobilization efforts surrounding World Alzheimer’s Day. Across the border in France, where numerous individuals live with the condition and new cases are diagnosed annually, clinical observers emphasize the critical need for sustained financial investment in research. Patrick Leprêtre, president of France Alzheimer 92, pointed to the rising epidemiological burden, noting that public health systems must proactively address future diagnostic demands.
Concurrently, clinical interventions continue to explore non-pharmacological management strategies. Therapeutic recreation programs, such as specialized tennis workshops, offer patients structured environments to support motor skills, reflection, and socialization. Participants diagnosed with the condition have reported that such physical activities provide a constructive outlet to manage the psychological impact of cognitive decline while researchers continue working toward disease-modifying therapies.
*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*